Mettler-Toledo International, Inc. (NYSE:MTD) Receives Average Recommendation of "Hold" from Brokerages

Key Points

• Mettler-Toledo International has received a consensus recommendation of "Hold" from twelve research firms, with seven analysts recommending holding the stock and five recommending a buy.
• The company's shares have a 1-year price target average of $1,336.50, with Barclays and Bank of America raising their price targets to $1,350.00 and $1,390.00, respectively.
• Mettler-Toledo reported an earnings per share of $10.09 for its last quarter, surpassing analysts' estimates, and has set guidance for FY 2025 EPS at 42.100-42.600.

Shares of Mettler-Toledo International, Inc. (NYSE:MTD - Get Free Report) have earned a consensus recommendation of "Hold" from the twelve research firms that are covering the company, MarketBeat Ratings reports. Seven analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 1 year price target among analysts that have updated their coverage on the stock in the last year is $1,336.50.

A number of research analysts recently weighed in on MTD shares. Barclays raised their price target on shares of Mettler-Toledo International from $1,325.00 to $1,350.00 and gave the company an "overweight" rating in a research report on Thursday, October 2nd. Bank of America raised their price objective on shares of Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the stock a "neutral" rating in a report on Monday, September 22nd. Citigroup raised their price objective on shares of Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the stock a "buy" rating in a report on Thursday, August 21st. Robert W. Baird raised their price objective on shares of Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the stock a "neutral" rating in a report on Monday, August 4th. Finally, Evercore ISI raised their price objective on shares of Mettler-Toledo International from $1,275.00 to $1,400.00 and gave the stock an "outperform" rating in a report on Tuesday, October 7th.

Mettler-Toledo International Price Performance

MTD opened at $1,359.14 on Friday. The company's 50-day moving average is $1,285.43 and its 200 day moving average is $1,193.56. Mettler-Toledo International has a fifty-two week low of $946.69 and a fifty-two week high of $1,438.46. The firm has a market capitalization of $28.00 billion, a P/E ratio of 34.42, a PEG ratio of 3.91 and a beta of 1.37.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last released its quarterly earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share for the quarter, beating analysts' consensus estimates of $9.58 by $0.51. Mettler-Toledo International had a net margin of 21.46% and a negative return on equity of 476.07%. The company had revenue of $983.22 million for the quarter, compared to analyst estimates of $957.41 million. During the same period last year, the firm earned $9.65 earnings per share. The firm's revenue was up 3.9% on a year-over-year basis. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. On average, equities research analysts expect that Mettler-Toledo International will post 42.71 earnings per share for the current year.

Insider Buying and Selling

In related news, Director Thomas P. Salice sold 1,062 shares of the firm's stock in a transaction dated Wednesday, August 13th. The shares were sold at an average price of $1,300.90, for a total transaction of $1,381,555.80. Following the completion of the sale, the director owned 283 shares in the company, valued at approximately $368,154.70. This trade represents a 78.96% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, CFO Shawn Vadala sold 300 shares of Mettler-Toledo International stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $1,325.00, for a total transaction of $397,500.00. Following the completion of the transaction, the chief financial officer owned 5,095 shares of the company's stock, valued at $6,750,875. The trade was a 5.56% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 1,827 shares of company stock worth $2,371,208. Insiders own 1.94% of the company's stock.

Hedge Funds Weigh In On Mettler-Toledo International

Several large investors have recently modified their holdings of the business. Vanguard Group Inc. increased its stake in shares of Mettler-Toledo International by 0.5% in the second quarter. Vanguard Group Inc. now owns 2,556,707 shares of the medical instruments supplier's stock worth $3,003,415,000 after purchasing an additional 13,342 shares in the last quarter. Bank of New York Mellon Corp increased its stake in shares of Mettler-Toledo International by 71.3% in the second quarter. Bank of New York Mellon Corp now owns 904,264 shares of the medical instruments supplier's stock worth $1,062,257,000 after purchasing an additional 376,419 shares in the last quarter. Alliancebernstein L.P. increased its stake in shares of Mettler-Toledo International by 1.1% in the second quarter. Alliancebernstein L.P. now owns 717,449 shares of the medical instruments supplier's stock worth $842,802,000 after purchasing an additional 8,121 shares in the last quarter. Geode Capital Management LLC increased its stake in shares of Mettler-Toledo International by 0.6% in the second quarter. Geode Capital Management LLC now owns 581,847 shares of the medical instruments supplier's stock worth $681,489,000 after purchasing an additional 3,383 shares in the last quarter. Finally, Price T Rowe Associates Inc. MD increased its stake in shares of Mettler-Toledo International by 5.5% in the first quarter. Price T Rowe Associates Inc. MD now owns 481,011 shares of the medical instruments supplier's stock worth $568,032,000 after purchasing an additional 25,272 shares in the last quarter. Hedge funds and other institutional investors own 95.07% of the company's stock.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.